Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
19.94
+0.16 (0.81%)
Jan 2, 2025, 4:00 PM EST - Market closed
KNSA Employees
Kiniksa Pharmaceuticals International, had 297 employees as of December 31, 2023. The number of employees increased by 77 or 35.00% compared to the previous year.
Employees
297
Change (1Y)
77
Growth (1Y)
35.00%
Revenue / Employee
$1,293,259
Profits / Employee
-$30,532
Market Cap
1.44B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
KNSA News
- 5 weeks ago - Kiniksa Pharmaceuticals to Present at 7th Annual Evercore ISI HealthCONx Conference - GlobeNewsWire
- 7 weeks ago - Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference - GlobeNewsWire
- 2 months ago - Kiniksa Pharmaceuticals International, plc (KNSA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution - GlobeNewsWire
- 2 months ago - Kiniksa Pharmaceuticals to Report Third Quarter 2024 Financial Results on October 29, 2024 - GlobeNewsWire
- 4 months ago - Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference - GlobeNewsWire
- 5 months ago - Kiniksa Pharmaceuticals: Improved Outlook For Arcalyst After Q2 Beat - Seeking Alpha
- 5 months ago - Kiniksa Pharmaceuticals International, plc (KNSA) Q2 2024 Earnings Call Transcript - Seeking Alpha